Michael Richman
Gründer bei NEXTCURE, INC.
Vermögen: 524 159 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Michael Richman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.
43
| Extinct | Medical Specialties | 43 |
| Public Company | Biotechnology | 30 | |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.
28
| Extinct | Pharmaceuticals: Major | 28 |
| Public Company | Pharmaceuticals: Major | 23 | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
22
| Subsidiary | Biotechnology | 22 |
12
| Subsidiary | Pharmaceuticals: Major | 12 |
PharmaFrontiers Corp.
9
| Extinct | Pharmaceuticals: Major | 9 |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
| Public Company | Pharmaceuticals: Major | 7 | |
Madison Vaccines, Inc.
 Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.
2
| Extinct | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Richman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | President Director of Finance/CFO Corporate Officer/Principal | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal General Counsel Comptroller/Controller/Auditor | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| Boston University | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| George Mason University | College/University | Graduate Degree Graduate Degree | |
| Texas A&M University | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Doctorate Degree | |
| University of Western Ontario | College/University | Doctorate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Chief Operating Officer Director/Board Member | |
| University of Maryland | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| ARVINAS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| GRITSTONE BIO, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| George Washington University Law School | College/University | Graduate Degree Graduate Degree | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of California, Davis | College/University | Undergraduate Degree Doctorate Degree | |
| The University of Connecticut School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| ARCELLX, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 44 |
| Kanada | 4 |
| Frankreich | 2 |
| Israel | 2 |
| Deutschland | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 21 |
| Commercial Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 586 |
| Corporate Officer/Principal | 229 |
| Independent Dir/Board Member | 186 |
| President | 88 |
| Chairman | 86 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Chau Khuong | 38 |
| Elaine Jones | 37 |
| Gregory Bailey | 36 |
| Helen Kim | 33 |
| David Kabakoff | 30 |
| Timothy Shannon | 28 |
| Edward Hurwitz | 27 |
| Briggs Morrison | 26 |
| Peter Kiener | 25 |
| James Geraghty | 25 |
| Jean Bizzari | 24 |
| Darlene Deptula-Hicks | 24 |
| David Hung | 24 |
| Melvin Booth | 23 |
| Lewis Williams | 23 |
- Börse
- Insiders
- Michael Richman
- Unternehmensverbindungen
